Analgesia in Lingual Frenulotomy in the Newborn
RE-GLU
Lingual Frenulotomy in the Newborn: a Randomized Clinical Trial to Evaluate the Analgesic Effect of a Water and Sugar Solution in a Minor Surgical Procedure
1 other identifier
interventional
72
1 country
1
Brief Summary
Ankyloglossia (tongue-tie) is a congenital anomaly characterized by a short lingual frenulum that limits the physiological tongue movement and occurs with an estimated prevalence between 4 and 10% of the newborns. This condition can be associated with difficulty in breastfeeding which can be painful for the mother, dysfunctional swallowing and future speech difficulties. The prevalence of nipple pain among women breastfeeding newborns with ankyloglossia is estimated to be between 36 and 80%. Since an early intervention can prevent the difficulties that may occur during the child's growth and can also improve the mothers and patients' quality of life, it is important to evaluate the lingual frenulum in the first days of life. The treatment of ankyloglossia consists in the frenulotomy which allows the release of the lingual frenulum and is a relatively simple procedure with few side effects and minimal post-operative. Different methods performed with or without local anaesthesia by means of scissors, blade, laser (etc.) are described in literature for the procedure the newborn. The hypothesis of the study is that the addition of a water and sugar solution to the standard analgesia with lidocaine may lead to a greater benefit in terms of pain control and determine the activation of different brain areas. The primary aim of the study is to evaluate whether the administration of a water and sugar solution to newborns undergoing frenulotomy receiving topical lidocaine as standard analgesic protocol, may lead to an additional benefit in terms of pain reduction evaluated according to the Neonatal Infant Pain Scale (NIPS). The secondary aim of the study is to evaluate through a Hitachi multichannel near-infrared spectroscopy (NIRS) the effects of the addition of a water and sugar solution to the standard analgesic protocol with topical lidocaine on the cortical activation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2020
CompletedFirst Posted
Study publicly available on registry
June 19, 2020
CompletedStudy Start
First participant enrolled
September 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedMay 7, 2025
May 1, 2025
4.3 years
June 18, 2020
May 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain reduction
The perception of pain in newborns will be evaluated according to the Internationally Validated Neonatal Infant Pain Scale (NIPS).This scale detects the presence of six behavioral expression signs of neonatal pain (facial expression, crying, respiratory pattern, arms and legs' activity, arousal state) and ranges from 0 (absence of pain) to 7 (maximal pain level).
30 seconds after the frenulotomy
Secondary Outcomes (2)
Pain reduction
During the frenulotomy
Cortical oxy-haemoglobin change
30 seconds after the frenulotomy
Study Arms (2)
Sugar and water solution
EXPERIMENTAL2 ml of a water and sugar solution (3 full-teaspoons of granulated sugar dissolved in half glass of water)
Sterile water
ACTIVE COMPARATOR2 ml of sterile water
Interventions
2 ml of a water and sugar solution (3 full-teaspoons of granulated sugar dissolved in half glass of water)
Eligibility Criteria
You may qualify if:
- Term newborns (37 - 41 weeks of gestational age) within the first 10 days of life;
- Birth weight ≥ 2500 grams;
- Presence of ankyloglossia;
- Indication to the frenulotomy according to the Hazelbaker Assessment Tool for Lingual Frenulum Function (HATLFF): anatomical-functional evaluation with a score lower than 8.
You may not qualify if:
- Syndromic diagnosis (genetic/hereditary);
- Pathology of main organ (heart disease, brain disease etc.);
- Drugs intake that may interfere with the collected data (sedatives).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Maternal and Child Health - IRCCS Burlo Garofolo-
Trieste, Trieste, 34137, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maddalena Chermetz, DDS MSc
Institute for maternal and child health Burlo Garofolo
- STUDY DIRECTOR
Milena Cadenaro, DDS MSc PhD
Institute for maternal and child health Burlo Garofolo
- PRINCIPAL INVESTIGATOR
Chiara Navarra, DDS MSc PhD
Institute for maternal and child health Burlo Garofolo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2020
First Posted
June 19, 2020
Study Start
September 18, 2020
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 7, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share